Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Malle

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Reviews. Immunology|April 19, 2020
A map of SARS-CoV-2 and host cell interactionsLouise Malle
Current Opinion in Immunology|June 26, 2021
Down syndrome and type I interferon: not so simpleLouise Malle, Dusan Bogunovic
Immunity|October 15, 2022
Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndromeLouise Malle, Marta Martin-Fernandez, Sofija Buta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 16, 2020
Individuals with Down syndrome hospitalized with COVID-19 have more severe diseaseLouise Malle, Cynthia Gao, Chin Hur, et al.
European Journal of Pediatrics|November 17, 2015
CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutationMiria Paula V Cavalcante, Juliana B Brunelli, Clarissa C Miranda, et al.
Kidney360|November 14, 2025
Cytokine-Driven Janus Kinase Signal Transducer and Activator of Transcription (JAK/STAT) Pathway Hyperactivity Predicts Disease Severity in Pediatric Focal Segmental GlomerulosclerosisCarol L Shen, Ashley Richardson, Marta Martin-Fernandez, et al.
Journal of Clinical Immunology|June 5, 2021
Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down SyndromeLouise Malle, Paul Bastard, Andrea Martin-Nalda, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2017
ReplyScott W Canna, Charlotte Girard, Louise Malle, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2016
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibitionScott W Canna, Charlotte Girard, Louise Malle, et al.
Journal of Clinical Immunology|May 16, 2017
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RNLeonardo O Mendonca, Louise Malle, Frank X Donovan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Reviews. Immunology|April 19, 2020
A map of SARS-CoV-2 and host cell interactionsLouise Malle
Current Opinion in Immunology|June 26, 2021
Down syndrome and type I interferon: not so simpleLouise Malle, Dusan Bogunovic
Immunity|October 15, 2022
Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndromeLouise Malle, Marta Martin-Fernandez, Sofija Buta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 16, 2020
Individuals with Down syndrome hospitalized with COVID-19 have more severe diseaseLouise Malle, Cynthia Gao, Chin Hur, et al.
European Journal of Pediatrics|November 17, 2015
CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutationMiria Paula V Cavalcante, Juliana B Brunelli, Clarissa C Miranda, et al.
Kidney360|November 14, 2025
Cytokine-Driven Janus Kinase Signal Transducer and Activator of Transcription (JAK/STAT) Pathway Hyperactivity Predicts Disease Severity in Pediatric Focal Segmental GlomerulosclerosisCarol L Shen, Ashley Richardson, Marta Martin-Fernandez, et al.
Journal of Clinical Immunology|June 5, 2021
Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down SyndromeLouise Malle, Paul Bastard, Andrea Martin-Nalda, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2017
ReplyScott W Canna, Charlotte Girard, Louise Malle, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2016
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibitionScott W Canna, Charlotte Girard, Louise Malle, et al.
Journal of Clinical Immunology|May 16, 2017
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RNLeonardo O Mendonca, Louise Malle, Frank X Donovan, et al.
Pageof 2